XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Previously Reported
Revision of Prior Period, Accounting Standards Update, Adjustment
Preferred Stock
Preferred Stock
Previously Reported
Common Stock
Common Stock
Previously Reported
Capital Surplus
Capital Surplus
Previously Reported
Retained Earnings
Retained Earnings
Previously Reported
Retained Earnings
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Accumulated Other Comprehensive Income/(Loss)
Previously Reported
Noncontrolling Interest
Noncontrolling Interest
Previously Reported
Balance, beginning of period (in shares) at Dec. 31, 2018       1,000 1,000 318,573 318,573                  
Balance, beginning of period at Dec. 31, 2018 $ 4,784,369 $ 4,785,380 $ (1,011) $ 95,624 $ 95,624 $ 199,108 $ 199,108 $ 3,029,425 $ 3,029,425 $ 1,541,397 $ 1,542,408 $ (1,011) $ (376,616) [1] $ (376,616) [1] $ 295,431 $ 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 103,405                 100,585         2,820  
Other comprehensive income (loss) 55,465                       55,465 [1]      
Comprehensive income (loss) 158,870                 100,585     55,465 [1]   2,820  
Cash dividends declared:                                
Preferred stock (1,550)                 (1,550)            
Common stock (44,864)                 (44,864)            
Common stock repurchased (in shares)           (3,594)                    
Common stock repurchased (53,436)         $ (2,246) [2]   (51,190) [2]                
Common stock issued for:                                
Stock options and restricted stock - equity awards (in shares)           382                    
Stock options and restricted stock - equity awards 520         $ 239   281                
Stock-based compensation expense 5,432             5,432                
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,820)                           (2,820)  
Balance, ending of period (in shares) at Mar. 31, 2019       1,000   315,361                    
Balance, end of period at Mar. 31, 2019 4,846,521     $ 95,624   $ 197,101   2,983,948   1,595,568     (321,151) [1]   295,431  
Balance, beginning of period (in shares) at Dec. 31, 2018       1,000 1,000 318,573 318,573                  
Balance, beginning of period at Dec. 31, 2018 4,784,369 4,785,380 (1,011) $ 95,624 $ 95,624 $ 199,108 $ 199,108 3,029,425 3,029,425 1,541,397 1,542,408 (1,011) (376,616) [1] (376,616) [1] 295,431 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 331,090                              
Other comprehensive income (loss) 135,962                              
Comprehensive income (loss) 467,052                              
Cash dividends declared:                                
Preferred stock (4,650)                              
Balance, ending of period (in shares) at Sep. 30, 2019       1,000   311,180                    
Balance, end of period at Sep. 30, 2019 4,996,043     $ 95,624   $ 194,487   2,925,309   1,725,846     (240,654)   295,431  
Balance, beginning of period (in shares) at Mar. 31, 2019       1,000   315,361                    
Balance, beginning of period at Mar. 31, 2019 4,846,521     $ 95,624   $ 197,101   2,983,948   1,595,568     (321,151) [1]   295,431  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 113,742                 110,890         2,852  
Other comprehensive income (loss) 58,662                       58,662 [2],[3]      
Comprehensive income (loss) 172,404                 110,890     58,662 [2],[3]   2,852  
Cash dividends declared:                                
Preferred stock (1,550)                 (1,550)            
Common stock (44,388)                 (44,388)            
Common stock repurchased (in shares) [2]           (3,654)                    
Common stock repurchased [2] (52,222)         $ (2,284)   (49,938)                
Common stock issued for:                                
Stock options and restricted stock - equity awards (in shares)           771                    
Stock options and restricted stock - equity awards 2,944         $ 482   2,462                
Stock-based compensation expense 5,224             5,224                
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,852)                           (2,852)  
Balance, ending of period (in shares) at Jun. 30, 2019       1,000   312,478                    
Balance, end of period at Jun. 30, 2019 4,926,081     $ 95,624   $ 195,299   2,941,696   1,660,520     (262,489) [1]   295,431  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 113,943                 111,060         2,883  
Other comprehensive income (loss) 21,835                       21,835      
Comprehensive income (loss) 135,778                 111,060     21,835   2,883  
Cash dividends declared:                                
Preferred stock (1,550)                 (1,550)            
Common stock (44,184)                 (44,184)            
Common stock repurchased (in shares)           (1,804)                    
Common stock repurchased (28,382)         $ (1,127)   (27,255)                
Common stock issued for:                                
Stock options and restricted stock - equity awards (in shares)           506                    
Stock options and restricted stock - equity awards 5,361         $ 315   5,046                
Stock-based compensation expense 5,822             5,822                
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,883)                           (2,883)  
Balance, ending of period (in shares) at Sep. 30, 2019       1,000   311,180                    
Balance, end of period at Sep. 30, 2019 4,996,043     $ 95,624   $ 194,487   2,925,309   1,725,846     (240,654)   295,431  
Balance, beginning of period (in shares) at Dec. 31, 2019       1,000 1,000 311,469 311,469                  
Balance, beginning of period at Dec. 31, 2019 4,979,951 5,076,008 (96,057) $ 95,624 $ 95,624 $ 194,668 $ 194,668 2,931,451 2,931,451 1,702,385 1,798,442 (96,057) (239,608) [3] (239,608) [3] 295,431 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 16,472                 13,620         2,852  
Other comprehensive income (loss) 103,444                       103,444 [3]      
Comprehensive income (loss) 119,916                 13,620     103,444 [3]   2,852  
Cash dividends declared:                                
Preferred stock (1,550)                 (1,550)            
Common stock (47,350)                 (47,350)            
Common stock repurchased (in shares)           (141)                    
Common stock repurchased (2,064)         $ (88)   (1,976)                
Common stock issued for:                                
Stock options and restricted stock - equity awards (in shares)           652                    
Stock options and restricted stock - equity awards 4,140         $ 407   3,733                
Stock-based compensation expense 7,281             7,281                
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,852)                           (2,852)  
Other (in shares) [4]           (117)                    
Other [4] (1,892)         $ (73)   (1,819)                
Balance, ending of period (in shares) at Mar. 31, 2020       1,000   311,863                    
Balance, end of period at Mar. 31, 2020 5,055,580     $ 95,624   $ 194,914   2,938,670   1,667,105     (136,164) [3]   295,431  
Balance, beginning of period (in shares) at Dec. 31, 2019       1,000 1,000 311,469 311,469                  
Balance, beginning of period at Dec. 31, 2019 4,979,951 $ 5,076,008 $ (96,057) $ 95,624 $ 95,624 $ 194,668 $ 194,668 2,931,451 $ 2,931,451 1,702,385 $ 1,798,442 $ (96,057) (239,608) [3] $ (239,608) [3] 295,431 $ 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 612,175                              
Other comprehensive income (loss) 99,138                              
Comprehensive income (loss) 711,313                              
Cash dividends declared:                                
Preferred stock (15,822)                              
Balance, ending of period (in shares) at Sep. 30, 2020       26,250   554,788                    
Balance, end of period at Sep. 30, 2020 8,144,142     $ 470,370   $ 346,742   5,061,079   2,110,990     (140,470)   295,431  
Balance, beginning of period (in shares) at Mar. 31, 2020       1,000   311,863                    
Balance, beginning of period at Mar. 31, 2020 5,055,580     $ 95,624   $ 194,914   2,938,670   1,667,105     (136,164) [3]   295,431  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 56,665                 53,814         2,851  
Other comprehensive income (loss) 1,366                       1,366 [3]      
Comprehensive income (loss) 58,031                 53,814     1,366 [3]   2,851  
Cash dividends declared:                                
Preferred stock (1,550)                 (1,550)            
Common stock (47,740)                 (47,740)            
Preferred stock issuance (in shares) (1,500 shares issued at $100,000 per share net of offering costs)       1,500                        
Preferred stock issuance (1,500 shares issued at $100,000 per share net of offering costs) 144,665     $ 144,665                        
Common stock repurchased (in shares)           (183)                    
Common stock repurchased (1,468)         $ (114)   (1,354)                
Common stock issued for:                                
Stock options and restricted stock - equity awards (in shares)           679                    
Stock options and restricted stock - equity awards           $ 424   (424)                
Stock-based compensation expense 3,718             3,718                
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,851)                           (2,851)  
Balance, ending of period (in shares) at Jun. 30, 2020       2,500   312,359                    
Balance, end of period at Jun. 30, 2020 5,208,385     $ 240,289   $ 195,224   2,940,610   1,671,629     (134,798) [3]   295,431  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net income 539,038                 536,061         2,977  
Other comprehensive income (loss) (5,672)                       (5,672)      
Comprehensive income (loss) 533,366                 536,061     (5,672)   2,977  
Cash dividends declared:                                
Preferred stock (12,722)                 (12,722)            
Common stock (84,095)                 (84,095)            
Common stock repurchased (in shares)           (88)                    
Common stock repurchased (837)         $ (56)   (781)                
Common stock issued for:                                
Stock options and restricted stock - equity awards (in shares)           138                    
Stock options and restricted stock - equity awards           $ 87   (87)                
Issued in business combination (in shares)       23,750   243,015                    
Issued in business combination 2,497,296     $ 230,081   $ 151,885   2,115,330                
Stock-based compensation expense 11,588             11,588                
Dividends declared - noncontrolling interest of subsidiary preferred stock (2,977)                           (2,977)  
Other (in shares)           (636)                    
Other (5,862)         $ (398)   (5,581)   117            
Balance, ending of period (in shares) at Sep. 30, 2020       26,250   554,788                    
Balance, end of period at Sep. 30, 2020 $ 8,144,142     $ 470,370   $ 346,742   $ 5,061,079   $ 2,110,990     $ (140,470)   $ 295,431  
[1] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income (loss) have been attributed solely to FHN as the controlling interest holder.
[2] Includes $51.5 million, $50.2 million, and $28.2 million repurchased under share repurchase programs in first, second and third quarter 2019, respectively.
[3] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income (loss) have been attributed solely to FHN as the controlling interest holder.(b)
[4] Represents shares canceled in connection with the resolution of remaining Capital Bank Financial Corporation ("CBF") dissenters' appraisal process.(c) Represents shares canceled to cover taxes on the IBKC equity compensation grants that automatically vested as part of the merger.